US 11141493
Compositions and methods for treating CEP290-associated disease
granted A61KA61K48/0008A61K48/0058
Quick answer
US patent 11141493 (Compositions and methods for treating CEP290-associated disease) held by Editas Medicine, Inc. expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Editas Medicine, Inc.
- Grant date
- Tue Oct 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K48/0008, A61K48/0058, A61K48/0066, A61K48/0091